Skip to main content
. 2015 Mar 8;2015(3):CD001954. doi: 10.1002/14651858.CD001954.pub4

Comparison 1. Azithromycin versus amoxycillin or amoxycillin‐clavulanate.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Clinical failure 15 2496 Risk Ratio (M‐H, Random, 95% CI) 1.09 [0.64, 1.85]
2 Clinical failure by diagnosis 15   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
2.1 Acute bronchitis 6 1296 Risk Ratio (M‐H, Random, 95% CI) 0.63 [0.45, 0.88]
2.2 Acute exacerbation of chronic bronchitis 9 808 Risk Ratio (M‐H, Random, 95% CI) 1.24 [0.46, 3.32]
2.3 Pneumonia 5 392 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.45, 1.94]
3 Clinical failure by age group 15   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
3.1 Adult 12 2112 Risk Ratio (M‐H, Random, 95% CI) 1.15 [0.60, 2.20]
3.2 Paediatric 3 384 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.45, 1.94]
4 Clinical failure by dose regimen of azithromycin 12 2112 Risk Ratio (M‐H, Random, 95% CI) 1.15 [0.60, 2.20]
4.1 500 mg once daily x 3 8 1631 Risk Ratio (M‐H, Random, 95% CI) 1.25 [0.55, 2.83]
4.2 500 mg single dose followed by 250 mg on day 2 to 5 4 481 Risk Ratio (M‐H, Random, 95% CI) 0.95 [0.25, 3.62]
5 Clinical failure by type of antibiotic in control group 15 2496 Risk Ratio (M‐H, Random, 95% CI) 1.09 [0.64, 1.85]
5.1 Amoxycillin 2 291 Risk Ratio (M‐H, Random, 95% CI) 0.41 [0.16, 1.05]
5.2 Amoxyclav 13 2205 Risk Ratio (M‐H, Random, 95% CI) 1.28 [0.71, 2.30]
6 Sensitivity analysis excluding one large trial 14 1742 Risk Ratio (M‐H, Random, 95% CI) 1.20 [0.69, 2.09]
7 Sensitivity analysis excluding three trials with missing data > 10% 12 2250 Risk Ratio (M‐H, Random, 95% CI) 1.13 [0.62, 2.03]
8 Sensitivity analysis with the condition of concealment 15 2496 Risk Ratio (M‐H, Random, 95% CI) 1.09 [0.64, 1.85]
8.1 Adequately concealed studies 3 281 Risk Ratio (M‐H, Random, 95% CI) 0.55 [0.25, 1.21]
8.2 Inadequately or unclearly concealed studies 12 2215 Risk Ratio (M‐H, Random, 95% CI) 1.32 [0.70, 2.49]
9 Microbial eradication 12 961 Risk Ratio (M‐H, Random, 95% CI) 0.95 [0.87, 1.03]
10 Adverse events 12 2406 Risk Ratio (M‐H, Random, 95% CI) 0.76 [0.57, 1.00]